UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) April 7, 2009
ALLSCRIPTS-MISYS HEALTHCARE SOLUTIONS, INC.
(Exact name of registrant as specified in its charter)
| Delaware | 000-32085 | 36-4392754 | ||
| (State or other jurisdiction of incorporation) |
(Commission File Number) | (IRS Employer Identification No.) |
222 Merchandise Mart, Suite 2024
Chicago, IL 60654
Registrant’s telephone number, including area code 1-866-358-6869
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
| ITEM 7.01. | Regulation FD Disclosure. |
Attached as Exhibit 99.1 hereto is an Investor Presentation dated April 2009, which is incorporated herein by reference.
This information is being furnished pursuant to Item 9 of this Report and shall not be deemed to be “filed” for the purposes of Section 18 of the Securities and Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section and will not be incorporated by reference into any registration statement filed by Allscripts Healthcare Solutions, Inc. under the Securities Act of 1933, as amended, unless specifically identified as being incorporated therein by reference. This Report will not be deemed an admission as to the materiality of any information in this Report that is being disclosed pursuant to Regulation FD.
Please refer to page 2 of Exhibit 99.1 for a discussion of certain forward-looking statements included therein and the risks and uncertainties related thereto.
| ITEM 9.01. | Financial Statements, Pro Forma Financial Information and Exhibits. |
| (d) | Exhibits: |
| 99.1 | Investor Presentation dated April 2009 |
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| ALLSCRIPTS-MISYS HEALTHCARE SOLUTIONS, INC. | ||||||||
| Date: April 7, 2009 | By: | /s/ William J. Davis | ||||||
| William J. Davis Chief Financial Officer | ||||||||
3
EXHIBIT INDEX
The following exhibits are filed herewith:
| Exhibit No. |
||
| 99.1 | Investor Presentation dated April 2009. |
 Copyright © 2008 AllscriptsMisys Healthcare, Inc. APRIL 2009 Investor Briefing EXHIBIT 99.1 |
Forward Looking Statements
This communication contains forward-looking statements within the meaning of the federal securities laws. Statements regarding future events, developments, the Company’s future performance, as well as management’s expectations, beliefs, intentions, plans, estimates or projections relating to the future are forward-looking statements within the meaning of these laws. These forward-looking statements are subject to a number of risks and uncertainties, some of which are outlined below. As a result, actual results may vary materially from those anticipated by the forward-looking statements. Among the important factors that could cause actual results to differ materially from those indicated by such forward-looking statements are: the volume and timing of systems sales and installations; length of sales cycles and the installation process; the possibility that products will not achieve or sustain market acceptance; the timing, cost and success or failure of new product and service introductions, development and product upgrade releases; competitive pressures including product offerings, pricing and promotional activities; our ability to establish and maintain strategic relationships; undetected errors or similar problems in our software products; compliance with existing laws, regulations and industry initiatives and future changes in laws or regulations in the healthcare industry; possible regulation of the Company’s software by the U.S. Food and Drug Administration; the possibility of product-related liabilities; our ability to attract and retain qualified personnel; our ability to identify and complete acquisitions, manage our growth and integrate acquisitions; the ability to recognize the benefits of the merger with Misys Healthcare Systems, LLC (“MHS”); the integration of MHS with the Company and the possible disruption of current plans and operations as a result thereof; the implementation and speed of acceptance of the electronic record provisions of the American Recovery and Reinvestment Act of 2009; maintaining our intellectual property rights and litigation involving intellectual property rights; risks related to third-party suppliers; our ability to obtain, use or successfully integrate third-party licensed technology; breach of our security by third parties; and the risk factors detailed from time to time in our reports filed with the Securities and Exchange Commission, including our 2007 Annual Report on Form 10-K available through the Web site maintained by the Securities and Exchange Commission at www.sec.gov. The Company undertakes no obligation to update publicly any forward-looking statement, whether as a result of new information, future events or otherwise.
 Copyright © 2008 AllscriptsMisys Healthcare, Inc. 2 Investor Briefing Glen Tullman Chief Executive Officer |
 3 |
 TRUE
NORTH The Stimulus 4 |
 5 What is in the $19 Billion? $17 billion + $2 billion = $19 billion Physician Incentives Incentive Bonuses from Medicare/Medicaid HHS Discretionary Funds Potential Areas Include: Standards Development, Grants (AHRQ, HRSA, CMS), HIE Infrastructure, Loans to the States for EHR, Regional HIT Resource Centers, Telemedicine, Efficacy Studies HHS = Health and Human Services AHRQ = Agency for Healthcare Research and Quality HRSA = Health Resources and Services Administration CMS = Centers for Medicare and Medicaid Services |
 6 One View of a Changed World TRUE NORTH Impact on EHR Adoption Practice Size Total # of Practices EHR Penetration (FY09) 1-3 Physicians 163,118 9% 4-9 Physician 27,282 18% 10-25 Physicians 7,906 25% 26+ Physicians 2,023 43% Total 200,329 |
 7 Understanding The Federal Incentives EHR Stimulus Funding $44,000 over 5 yrs. + PQRI Incentive $3,000 - $5,000/yr. estimate If you start now… + ePrescribe Incentive $3,000-5,000/yr. estimate PQRI = Physician Quality Reporting Initiative |
 8 Why Allscripts › Significant Footprint: 150,000 MDs, 700 Hospitals, 6,000 Post Acute Facilities, 600 Homecare Agencies › All Sizes and Settings: Ambulatory and Acute, Primary Care and Specialty, Small to Large › Diversified Portfolio: Clinical and Business Solutions › All World-Class: Top Rated Consistently › Significant Breakthroughs: Innovation Comes Standard › Real Utilization: Not Just Implementation › Strong ROI: The Solution That Pays You Back › Delivering the Next Step: Connect to Health™ |
 Includes: •ePrescribe •Connect •Payerpath •Document Management Includes Connected Physician, plus: Enterprise and/or Professional EHR/ PM with connections to commercial labs and imaging centers Includes Connected EHR, plus: Connections to other physicians, hospital ED Systems, CM systems, HIS systems, Clinical
trial systems, CMS reporting, State reporting programs and
RHIO’s For physicians not yet ready for an EHR For physicians ready to become “Operable” For Physicians Ready to “Connect to Health” A Comprehensive Portfolio 9 |
 10 |
 Innovation Overview 11 |
 Copyright © 2008 AllscriptsMisys Healthcare, Inc. 12 Innovation at Allscripts Dan Michelson Chief Marketing Officer |
 13 The Time is NOW. › Funding is Front Loaded – $30,000 (close to 70% of the funding) comes in the first two years › You Need to Demonstrate Meaningful Utilization – Purchase and Implementation are not enough - you must use it › Funding is Time Stamped – Incentives start in 2011, decrease over time and penalties begin in 2015 |
 14 Allscripts vision The way Allscripts is bringing heath to healthcare. Allscripts; 2008 < LL innovation in-no-va-tion tech-nol-o-gy |
 15 A Simple Approach Get it Certified Get it Connected Get it Cool Get it Sold Get it Used |
 16 16 1. Listen to your clients 2. Solve a problem that no one else is solving 3. Do it in a way that no one else is doing it 4. Make it stunningly simple 5. Look for the answers that are all around us Innovation Technology: Guiding Principles |
 A
Simple Idea: Checking in at my doctor’s office should be as easy
as checking in for a flight. 17 |
 18 |
 19 The Problem: • Increasing administrative costs and patient wait times, time-consuming patient information updates, and decreasing revenues due to lost co-pay collections Allscripts Patient Kiosk The Solution: • An easy to use, touch screen based system that enables practices to improve patient and staff satisfaction, streamline administrative processes, accelerate cash flow, and increase revenue |
 A
Simple Idea: Where is my EHR at 3 AM? 20 |
 21 The Problem: • When physicians are away from their office, the lack of easy access to their EHR results in disruption to personal life, inefficient use of time, undocumented care, increased liability and medical errors. Allscripts Remote The Solution: • In seconds, physicians can access the EHR through via the iPhone |
 22 |
 23 ? |